^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CD19-CD34 CAR transduced T cells

    i
    Other names: CD19-CD34 CAR transduced T cells
    Associations

    News

    Trials
    Company:
    Loyola University
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    over1year
    CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies (clinicaltrials.gov)
    P1, N=24, Active, not recruiting, Loyola University | Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2021 --> Aug 2022
    Enrollment closed • Trial primary completion date
    |
    CD19 (CD19 Molecule) • CD34 (CD34 molecule)
    |
    cyclophosphamide • fludarabine IV • CD19-CD34 CAR transduced T cells